demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 outpatients
antiandrogenic
dutasteride Cadegiani ...

1 studies excluded by filtering options 3

6487 Lazzeri, 2021 0130selection pending